Cargando…
Barriers to family history collection among Spanish-speaking primary care patients: a BRIDGE qualitative study
OBJECTIVES: Family history is an important tool for assessing disease risk, and tailoring recommendations for screening and genetic services referral. This study explored barriers to family history collection with Spanish-speaking patients. METHODS: This qualitative study was conducted in two US hea...
Autores principales: | Liebermann, Erica, Taber, Peter, Vega, Alexis S., Daly, Brianne M., Goodman, Melody S., Bradshaw, Richard, Chan, Priscilla A., Chavez-Yenter, Daniel, Hess, Rachel, Kessler, Cecilia, Kohlmann, Wendy, Low, Sara, Monahan, Rachel, Kawamoto, Kensaku, Del Fiol, Guilherme, Buys, Saundra S., Sigireddi, Meenakshi, Ginsburg, Ophira, Kaphingst, Kimberly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757734/ https://www.ncbi.nlm.nih.gov/pubmed/36532299 http://dx.doi.org/10.1016/j.pecinn.2022.100087 |
Ejemplares similares
-
Investigation of interest in and timing preference for cancer predisposition testing and expanded carrier screening among women of reproductive age
por: Zhong, Lingzi, et al.
Publicado: (2023) -
Association of Disparities in Family History and Family Cancer History in the Electronic Health Record With Sex, Race, Hispanic or Latino Ethnicity, and Language Preference in 2 Large US Health Care Systems
por: Chavez-Yenter, Daniel, et al.
Publicado: (2022) -
Patient Interactions With an Automated Conversational Agent Delivering Pretest Genetics Education: Descriptive Study
por: Chavez-Yenter, Daniel, et al.
Publicado: (2021) -
Development of a storytelling communication facilitation tool (SCFT) to facilitate discussion of complex genetic diagnoses between parents and their children: A pilot study using 22q11.2 deletion syndrome as a model condition
por: Bogatan, Simina, et al.
Publicado: (2022) -
“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy
por: Head, Katharine J., et al.
Publicado: (2022)